Skip to main content
. 2022 Jan 29;15:65–79. doi: 10.2147/PGPM.S347018

Table 1.

Characteristics of Patients with T2DM and Controls

Variable Cases (n = 500) Controls (n = 501) p
Age (years, mean ± SD) 59.87 ± 12.87 59.85 ± 9.34 0.973
>60/≤60 240/260 268/233
Gender, Male/Female 358/142 358/143 0.508
BMI (kg/m2) <24/≥24 203/239 130/188
Unavailable 58 183
Smoking, Yes/No 219/280 98/164
Unavailable 1 239
Drinking, Yes/No 109/385 103/140
Unavailable 6 258
T2DM duration (years) >10/≤10 193/307
Fasting blood glucose (mmol/L) 8.14 ± 3.35 5.65 ± 0.51 <0.001
Total cholesterol (mmol/L) 4.18 ± 2.01 4.93 ± 4.00 <0.001
Triglyceride (mmol/L) 1.91 ± 1.90 1.74 ± 0.97 0.088
LDL-C (mmol/L) 2.46 ± 0.90 2.61 ± 0.76 0.012
HDL-C (mmol/L) 1.05 ± 0.72 1.16 ± 0.55 0.024
Urea (mmol/L) 6.52 ± 3.26 5.42 ± 2.78 <0.001
Creatinine (μmol/L) 71.20 ± 52.66 68.74 ± 12.87 0.322
GFR (mL/min) 96.62 ± 22.22 96.07 ± 19.78 0.710
Serum uric acid (μmol/L) 333.17 ± 99.15 318.33 ± 76.64 0.013
Diabetic complications
Diabetic nephropathy 146
Diabetic retinopathy 69
T2DM with coronary heart disease 126
T2DM with hypertension 269

Notes: p values were calculated by χ2 test for continuous variables and Student’s t test for categorical variables. Bold values indicate that p < 0.05 indicates statistical difference.

Abbreviations: T2DM, type 2 diabetes mellitus; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; UCRP, ubiquitin cross-reactive protein.